by Kazeem Olalekan MRPharmS If asked to describe one of my passions, it will have to be looking after children’s welfare. I am also passionate about pharmacy and quite keen to promote professional joint working and put the care user at the centre of everything we do.
Read more →
A class 1 drug alert (FOR IMMEDIATE ACTION) was posted on the MHRA website last week for Co-codamol 8/500 (codeine phosphate 8mg, paracetamol 500mg) containing rogue Co-codamol 30/500 tablets! The brand affected was manufactured by Wockhardt UK Ltd. Batch No: LL11701. Excerpts from the MHRA website
Read more →
by Kazeem Olalekan MRPharmS Clearly do you don’t think the above statement is profound! Everyone knows by now the inherent dangers of smoking. In 2007, I posted a piece on the Iforg weblog in anticipation of the introduction of Smoke-free initiative across England. I am going to repeat
Read more →
by Kazeem Olalekan I was at the Wessex Pharmacy Forum Conference organised by the Royal Pharmaceutical Society late last year (link). It was aptly title the: ‘Indispensables!’. The conference was well attended but I was particularly enthused by the attendance of Pre-registration students. These are our future…pharmacy’s
Read more →
by Kazeem Olalekan The Royal Pharmaceutical Society is navigating through a seismic wave of change with the talent of a professional surfer. The wave can be precarious but the Society is navigating through it gracefully and effortlessly – or so it seems. It is for this reason
Read more →
by Kazeem Olalekan MRPharmS Following on from a previous article on the NHS, I promised to try and get an interview with Dr Mark Tomlin. Well I have kept my promise. Today we publish the full interview. Dr Tomlin talk on a range of issues. He talks
Read more →
by Kazeem Olalekan MRPharmS Early result from the ALiskiren Trial In Type 2 diabetes Using cardiovascular and renal Disease Endpoints (ALTITUDE) study has shown that: study patients were unlikely to benefit from aliskiren; and an increased incidence of non-fatal strokes, renal complications (including acute renal failure), hyperkalaemia
Read more →
Southampton, Hampshire, Isle of Wight and Portsmouth NHS are doing their bit to raise awareness of the prescription waste issue. Only order what you need. Visit their website
Read more →
by Kazeem Olalekan A safety alert has come to our attention via the MHRA: Following a review by the Commission on Human Medicines (CHM), the marketing authorisation (licence) for levothyroxine 100 microgram tablets manufactured by Teva has been suspended. Teva levothyroxine 100 microgram tablets will cease to
Read more →
Previous post (link) highlighted the scale of the problem of medicines waste. A new website: medicinewaste.com has been launched and it details what you can do to help reduce the number of wasted medicines in the NHS. Some great tips include: Let your GP or Pharmacist know
Read more →
